The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions &

Status Not yet recruiting

Clinical Trial Summary

Dementia is a significant public health problem, affecting 47 million people worldwide in 2015, according to World Health Organization data. It is expected to increase to 75 million in 2030 and reach 132 million in 2050. Royal jelly is used as a supplement in treating of cancer, hypertension, diabetes and neurodegenerative diseases due to its antioxidant, anti-inflammatory, neuroprotective, cardioprotective, anti-proliferative and anti-fatigue properties. There are preclinical studies on the curative and protective effects of royal jelly on cognitive functions. This randomized controlled, double-blind clinical trial is aimed to study the effect of oral use of lyophilized royal jelly for 4 weeks on immune system cytokine levels and cognitive functions in individuals aged 50-80 years without any neurological disease diagnosis. Primary outcome measures are the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale, and the Geriatric Depression Scale. Secondary outcome measures are serum interleukin-1β, interleukin-6, interleukin-10, tumor necrosis factor-α and transforming growth factor-β levels.

Clinical Trial Description

Volunteers who apply to Bağcılar Medipol Mega University Hospital Neurology Polyclinic will be recruited, and their demographic information will be recorded. Volunteers who meet eligibility criteria will be randomly divided into three groups considering age groups (50-64 years old and 65-80 years old). Primary and secondary outcome measures will be evaluated in volunteers. The results obtained will be recorded. Diet recommendations will be made to the volunteers for four weeks. The products detailed in the protocol will be used by the volunteers orally for four weeks on an empty stomach in the morning. Primary and secondary outcome measures will be reassessed in volunteers on day 28. The results obtained will be recorded. Obtained results will be evaluated statistically. ;

Study Design

Related Conditions & MeSH terms

Cognitive Change

Clinical Trial Details

NCT number	NCT06404203
Study type	Interventional
Source	Medipol University
Contact	Muhammet AB Baylan, MD
Phone	+90 (530) 694 74 25
Email	muhammet.baylan@std.medipol.edu.tr
Status	Not yet recruiting
Phase	N/A
Start date	July 1, 2024
Completion date	June 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05712005` - Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
Completed	`NCT05343208` - Effectiveness of Online Therapy to Prevent Burnout	N/A
Active, not recruiting	`NCT05143294` - Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions	N/A
Completed	`NCT05267730` - Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions	N/A
Completed	`NCT03987477` - Online Intervention to Modify Interpretation Biases in Depression	N/A
Completed	`NCT03695003` - Cognitive Effects of Sage in Healthy Humans	N/A
Completed	`NCT05075850` - Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection
Recruiting	`NCT05273996` - Predictors of Cognitive Outcomes in Geriatric Depression	Phase 4
Completed	`NCT03674281` - The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System	N/A
Completed	`NCT03689348` - Acute and Chronic Effects of Avena Sativa on Cognition and Stress	N/A
Active, not recruiting	`NCT05229705` - Exercise in Older Adults at Risk for Type 2 Diabetes	N/A
Suspended	`NCT05001789` - Cognitive Functioning in Opioid Use Disorder	N/A
Terminated	`NCT03337282` - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Recruiting	`NCT05014399` - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed	`NCT03657537` - Effects of Ketone Bodies on Cognition in Type 2 Diabetes	Phase 1
Completed	`NCT05543811` - The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology	N/A
Recruiting	`NCT05699226` - Amplitude Titration to Improve ECT Clinical Outcomes	N/A
Recruiting	`NCT05026541` - Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators	N/A
Active, not recruiting	`NCT03255499` - Efficacy of the MovinCog Intervention in Children	N/A
Not yet recruiting	`NCT06252376` - Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms